These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

770 related articles for article (PubMed ID: 17391818)

  • 1. Establishment of a mink enteritis vaccine production process in stirred-tank reactor and Wave Bioreactor microcarrier culture in 1-10 L scale.
    Hundt B; Best C; Schlawin N; Kassner H; Genzel Y; Reichl U
    Vaccine; 2007 May; 25(20):3987-95. PubMed ID: 17391818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wave microcarrier cultivation of MDCK cells for influenza virus production in serum containing and serum-free media.
    Genzel Y; Olmer RM; Schäfer B; Reichl U
    Vaccine; 2006 Aug; 24(35-36):6074-87. PubMed ID: 16781022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum-free influenza virus production avoiding washing steps and medium exchange in large-scale microcarrier culture.
    Genzel Y; Fischer M; Reichl U
    Vaccine; 2006 Apr; 24(16):3261-72. PubMed ID: 16472544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A microcarrier cell culture process for propagating rabies virus in Vero cells grown in a stirred bioreactor under fully animal component free conditions.
    Rourou S; van der Ark A; van der Velden T; Kallel H
    Vaccine; 2007 May; 25(19):3879-89. PubMed ID: 17307281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of a production process in a membrane-aerated stirred tank and up to 1000-L airlift bioreactors using BHK-21 cells and chemically defined protein-free medium.
    Hesse F; Ebel M; Konisch N; Sterlinski R; Kessler W; Wagner R
    Biotechnol Prog; 2003; 19(3):833-43. PubMed ID: 12790647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of virus yield as a strategy to improve rabies vaccine production by Vero cells in a bioreactor.
    Trabelsi K; Rourou S; Loukil H; Majoul S; Kallel H
    J Biotechnol; 2006 Jan; 121(2):261-71. PubMed ID: 16153733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of yellow fever virus in microcarrier-based Vero cell cultures.
    Souza MC; Freire MS; Schulze EA; Gaspar LP; Castilho LR
    Vaccine; 2009 Oct; 27(46):6420-3. PubMed ID: 19559120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on isolation, serum-free cultivation and manufacture of mink enteritis virus optimized for vaccine preparation.
    Zhang DL
    Biologicals; 1997 Mar; 25(1):103-11. PubMed ID: 9167014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral antigen production in cell cultures on microcarriers Bovine parainfluenza 3 virus and MDBK cells.
    Conceição MM; Tonso A; Freitas CB; Pereira CA
    Vaccine; 2007 Nov; 25(45):7785-95. PubMed ID: 17920165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New milliliter-scale stirred tank bioreactors for the cultivation of mycelium forming microorganisms.
    Hortsch R; Stratmann A; Weuster-Botz D
    Biotechnol Bioeng; 2010 Jun; 106(3):443-51. PubMed ID: 20198653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing enterovirus A71 vaccine production yield by microcarrier profusion bioreactor culture.
    Liu CC; Wu SC; Wu SR; Lin HY; Guo MS; Yung-Chih Hu A; Chow YH; Chiang JR; Shieh DB; Chong P
    Vaccine; 2018 May; 36(22):3134-3139. PubMed ID: 28274636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new MDCK suspension line cultivated in a fully defined medium in stirred-tank and wave bioreactor.
    Lohr V; Genzel Y; Behrendt I; Scharfenberg K; Reichl U
    Vaccine; 2010 Aug; 28(38):6256-64. PubMed ID: 20638458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Online monitoring of microcarrier based fibroblast cultivations with in situ microscopy.
    Rudolph G; Lindner P; Gierse A; Bluma A; Martinez G; Hitzmann B; Scheper T
    Biotechnol Bioeng; 2008 Jan; 99(1):136-45. PubMed ID: 17546690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microcarrier-based MDCK cell culture system for the production of influenza H5N1 vaccines.
    Hu AY; Weng TC; Tseng YF; Chen YS; Wu CH; Hsiao S; Chou AH; Chao HJ; Gu A; Wu SC; Chong P; Lee MS
    Vaccine; 2008 Oct; 26(45):5736-40. PubMed ID: 18761387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large-scale propagation of a replication-defective adenovirus vector in stirred-tank bioreactor PER.C6 cell culture under sparging conditions.
    Xie L; Metallo C; Warren J; Pilbrough W; Peltier J; Zhong T; Pikus L; Yancy A; Leung J; Auniņs JG; Zhou W
    Biotechnol Bioeng; 2003 Jul; 83(1):45-52. PubMed ID: 12740932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of a feline parvovirusvaccine using monolayer cell systems in roller flasks and microcarriers.
    Bergman R; Sundquist B; Ströman L
    Dev Biol Stand; 1983; 55():77-8. PubMed ID: 6677542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of cell culture (MDCK) derived live attenuated influenza vaccine (LAIV) in a fully disposable platform process.
    George M; Farooq M; Dang T; Cortes B; Liu J; Maranga L
    Biotechnol Bioeng; 2010 Aug; 106(6):906-17. PubMed ID: 20589670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a measles vaccine production process in MRC-5 cells grown on Cytodex1 microcarriers and in a stirred bioreactor.
    Trabelsi K; Majoul S; Rourou S; Kallel H
    Appl Microbiol Biotechnol; 2012 Feb; 93(3):1031-40. PubMed ID: 21935589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of different bioreactor systems for the production of high titer retroviral vectors.
    Merten OW; Cruz PE; Rochette C; Geny-Fiamma C; Bouquet C; Gonçalves D; Danos O; Carrondo MJ
    Biotechnol Prog; 2001; 17(2):326-35. PubMed ID: 11312711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High immunogenic enterovirus 71 strain and its production using serum-free microcarrier Vero cell culture.
    Liu CC; Lian WC; Butler M; Wu SC
    Vaccine; 2007 Jan; 25(1):19-24. PubMed ID: 16919374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.